Sanuwave Health (SNWV) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
11 Jun, 2026Opening remarks and agenda
Meeting called to order by CEO, with CFO appointed as secretary and inspector of election designated.
Agenda and voting procedures reviewed, with encouragement to review agenda online.
Notice of meeting mailed to stockholders on April 29, 2026.
Board and executive committee updates
Five directors nominated for election to serve until the 2027 annual meeting.
Shareholder proposals
Five proposals presented, including election of directors, ratification of accounting firm, and advisory vote on executive compensation.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Sanuwave Health
- Q2 2026 saw record applicator sales but lower revenue and margins amid CMS-driven disruption.SNWV
Q2 2026 - UltraMIST leverages clinical evidence and a consumables model to drive growth amid industry shifts.SNWVPlanet MicroCap Las Vegas 2026
- Innovative ultrasound wound care system drives growth with high margins and strong clinical results.SNWVInvestor presentation
- Q1 2026 set a revenue record with improved net loss and strong outlook for continued growth.SNWVQ1 2026
- Annual meeting to vote on directors, auditor, and executive pay, with strong governance focus.SNWVProxy filing
- Key votes include director elections, auditor ratification, and executive pay approval.SNWVProxy filing
- Record Q2 revenue and net income, with strong Q3 growth expected but ongoing capital risks.SNWVQ2 2024
- Merger deadline extended to June 30, targeting Cboe listing and 50% revenue growth.SNWVM&A Announcement
- Q1 2025 revenue rose 61% to $9.3M with record placements, margin gains, and ongoing risk factors.SNWVQ1 2025